NCT07050459 - A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors | Biotech Hunter

Enrollment

220

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions

Locally Advanced Solid Tumors

Interventions

DRUG

SIM0686

Administered intravenously

DRUG

SIM0686

Administered intravenously

Trial Locations (10)

100021

NOT_YET_RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

150081

NOT_YET_RECRUITING

Harbin Medical University Cancer Hospital, Haerbin

200032

NOT_YET_RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

200131

RECRUITING

Shanghai Gobroad Cancer Hospital, Shanghai

210008

RECRUITING

Nanjing Tianyinshan Hospital, Nanjing

250117

NOT_YET_RECRUITING

Cancer Hospital of Shandong First Medical University（Shandong Cancer Hospital&Institute）, Jinan

300060

NOT_YET_RECRUITING

Tianjin Cancer Hospital, Tianjin

410017

NOT_YET_RECRUITING

Hunan Cancer Hospital, Changsha

450003

NOT_YET_RECRUITING

The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou

610040

RECRUITING

Sichuan Cancer Hospital, Chengdu